TABLE 1.
Description of study population
| Patient group | No. of patientsa | Median age (range) (yr) | No. from:
|
No. with HIV statusb:
|
||||
|---|---|---|---|---|---|---|---|---|
| Africa | France | Other | P | N | ND | |||
| Tuberculosis group | ||||||||
| Positive culture | 18 (10/8) | 42 (23-89) | 5 | 6 | 7 | 2 | 11 | 5 |
| Positive histology, negative culture | 7 (6/1) | 40 (26-54) | 2 | 3 | 2 | 1 | 4 | 0 |
| Treated; negative histology and culture | 5 (5/0) | 39 (30-56) | 5 | 0 | 0 | 2 | 3 | 1 |
| Total | 30 (21/9) | 41 (23-89) | 12c | 9 | 9d | 5 | 18 | 6 |
| Nontuberculosis group | 90 (60/30) | 47 (7-91) | 29 | 43 | 18 | 19 | 33 | 39 |
| Total | 120 (81/39) | 47 | 41 | 52 | 27 | 24 | 51 | 45 |
a
Number in parentheses, male/female.
b
P, positive; N, negative; ND, not done.
c
Algeria, Mali, Madagascar, Congo, Morocco, Chad, Liberia, Ivory Coast, and Zaire.
d
India, Sri Lanka, China, Cambodia, Turkey, and Pakistan.